6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl-

Modify Date: 2024-02-05 15:18:28

6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl- Structure
6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl- structure
Common Name 6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl-
CAS Number 3033-29-2 Molecular Weight 449.27000
Density N/A Boiling Point 441ºC at 760mmHg
Molecular Formula C19H38O2SSn Melting Point N/A
MSDS N/A Flash Point 220.5ºC

 Names

Name 2,2-dioctyl-1,3,2-oxathiastanninan-6-one
Synonym More Synonyms

 Chemical & Physical Properties

Boiling Point 441ºC at 760mmHg
Molecular Formula C19H38O2SSn
Molecular Weight 449.27000
Flash Point 220.5ºC
Exact Mass 450.16100
PSA 51.60000
LogP 6.82970

 Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RP4400000
CHEMICAL NAME :
6H-1,3,2-Oxathiastannin-6-one, dihydro-2,2-dioctyl-
CAS REGISTRY NUMBER :
3033-29-2
BEILSTEIN REFERENCE NO. :
4922183
LAST UPDATED :
199712
DATA ITEMS CITED :
28
MOLECULAR FORMULA :
C19-H38-O2-S-Sn
MOLECULAR WEIGHT :
449.32
WISWESSER LINE NOTATION :
T6S-SN-OVTJ B8 B8

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1850 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 19,934,1969
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
6600 ug/kg
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 35,63,1976 *** REVIEWS *** ACGIH TLV-TWA 0.1 mg(Sn)/m3;STEL 0.2 mg/m3 (skin) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 TOXICOLOGY REVIEW EVHPAZ EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents, Washington, DC 20402) No.1- 1972- Volume(issue)/page/year: 4,61,1973 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 0.1 mg(Sn)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,258,1971 OSHA PEL (Gen Indu):8H TWA 0.1 mg(Sn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 0.1 mg(Sn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 0.1 mg(Sn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 0.1 mg(Sn)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 0.1 mg(Sn)/m3;Skin JAN 1993 OEL-BELGIUM:TWA 0.1 mg(Sn)/m3;Skin JAN 1993 OEL-DENMARK:TWA 0.1 mg(Sn)/m3;Skin JAN 1993 OEL-FINLAND:TWA 0.1 mg(Sn)/m3;STEL 0.3 mg(Sn)/m3;Skin JAN 1993 OEL-FRANCE:TWA 0.1 mg(Sn)/m3;STEL 0.2 mg(Sn)/m3 JAN 1993 OEL-GERMANY:TWA 0.1 mg(Sn)/m3;Skin JAN 1993 OEL-HUNGARY:STEL 0.1 mg(Sn)/m3;Skin JAN 1993 OEL-THE NETHERLANDS:TWA 0.1 mg(Sn)/m3;Skin JAN 1993 OEL-THE PHILIPPINES:TWA 0.1 mg(Sn)/m3 JAN 1993 OEL-SWEDEN:TWA 0.1 mg(Sn)/m3;STEL 0.2 mg(Sn)/m3;Skin JAN 1993 OEL-SWITZERLAND:TWA 0.1 mg(Sn)/m3;STEL 0.2 mg(Sn)/m3;Skin JAN 1993 OEL-THAILAND:TWA 0.1 mg(Sn)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 0.1 mg(Sn)/m3;STEL 0.2 mg(Sn)/m3;Skin JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO ORGANOTIN COMPOUND-air:10H TWA 0.1 mg(Sn)/m3 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992

 Synthetic Route

~%

6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl- Structure

6H-1,3,2-Oxathi...

CAS#:3033-29-2

Literature: Deutsche Advance Prod. Patent: DE1020331 , 1953 ;

 Precursor & DownStream

Precursor  1

DownStream  0

 Synonyms

Dioctyltin S,O-3-mercaptopropionate
EINECS 221-218-4
6H-1,3,2-OXATHIASTANNIN-6-ONE,DIHYDRO-2,2-DIOCTYL
dihydro-2,2-dioctyl-6H-1,3,2-oxathiastannin-6-one
Dioctyltin mercaptopropionate
Dioctyltin 3-mercaptopropionate-O,S
Top Suppliers:I want be here

Get all suppliers and price by the below link:

6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl- suppliers

6H-1,3,2-Oxathiastannin-6-one,dihydro-2,2-dioctyl- price

Related Compounds: More...
6H-1,3,2-Oxathiastannin-6-one,2,2-dibutyldihydro-
78-06-8
dihydro-2,2-dimethyl-6H-1,3,2-oxathiastannin-6-one
32673-05-5
2-butyl-2-[[3-[(2-butyldihydro-6-oxo-4H-1,3,2-oxathiastannin-2-yl)oxy]-3-oxopropyl]thio]dihydro-6H-1,3,2-oxathiastannin-6-one
58098-20-7
5-tert-Butyl-3,6-dihydro-2-hydrazino-1,3,4-thiadizine
158035-17-7
6H-1,3-Oxazin-6-one, 2,3-dihydro-2-(iminoethylidene)-4-methyl-, (2E)- (9CI)
652995-60-3
6H-1,3,4-Thiadiazin-6-one, 2-amino-4,5-dihydro-5,5-dimethyl- (9CI)
375354-68-0
6H-1,3,5-Triazepin-6-one, 2,4-diamino-1,7-dihydro-1-methyl- (9CI)
501359-93-9
6H-[1,3]Dioxolo[5,6]benzofuro[3,2-c][1]benzopyran-3-ol,6a,12a-dihydro-2-(3-methyl-2-butenyl)-, (6aR-cis)- (9CI)
33909-74-9
6H-[1]Benzopyrano[3,2-c][1,8]naphthyridin-6-one,7-(1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridin-3-yl)-4,7-dihydro-(9CI)
393127-74-7
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
1-(4-(2-Hydroxyethyl)piperazin-1-yl)-3-((2-methylbut-3-en-2-yl)oxy)propan-2-ol
1049562-73-3
3-Oxo-3-(5-oxo-1-m-tolyl-pyrrolidin-3-yl)-propionic acid methyl ester
1229627-23-9
2-((1-(3-chlorophenyl)-5-(p-tolyl)-1H-imidazol-2-yl)thio)-1-(indolin-1-yl)ethanone
1207058-35-2
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4